Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark T Esser

Showing results (21-30 of 99) with videos related to

Pageof 10
Sort By:
Human Vaccines|July 6, 2007
Antibodies from women immunized with Gardasil cross-neutralize HPV 45 pseudovirionsJudith F Smith, Michelle Brownlow, Martha Brown, et al.
Msphere|April 26, 2019
Development and Standardization of a High-Throughput Multiplex Immunoassay for the Simultaneous Quantification of Specific Antibodies to Five Respiratory Syncytial Virus ProteinsRutger M Schepp, Cornelis A M de Haan, Deidre Wilkins, et al.
Respiratory Research|April 2, 2020
Microbial burden and viral exacerbations in a longitudinal multicenter COPD cohortJerome Bouquet, David E Tabor, Jonathan S Silver, et al.
Vaccine|April 23, 2016
A phase 1a, first-in-human, randomized study of a respiratory syncytial virus F protein vaccine with and without a toll-like receptor-4 agonist and stable emulsion adjuvantJudith Falloon, Fei Ji, Craig Curtis, et al.
Influenza and Other Respiratory Viruses|March 4, 2020
Characterization of human respiratory syncytial virus (RSV) isolated from HIV-exposed-uninfected and HIV-unexposed infants in South Africa during 2015-2017Hui Liu, Bin Lu, David E Tabor, et al.
Antimicrobial Agents and Chemotherapy|November 1, 2016
Safety, Tolerability, and Pharmacokinetics of MEDI4893, an Investigational, Extended-Half-Life, Anti-Staphylococcus aureus Alpha-Toxin Human Monoclonal Antibody, in Healthy AdultsXiang-Qing Yu, Gabriel J Robbie, Yuling Wu, et al.
Infection and Immunity|December 22, 2017
Prevalence of IgG and Neutralizing Antibodies against Staphylococcus aureus Alpha-Toxin in Healthy Human Subjects and Diverse Patient PopulationsYuling Wu, Xu Liu, Ahmad Akhgar, et al.
Journal of Virology|July 5, 2002
Priming of human papillomavirus type 11-specific humoral and cellular immune responses in college-aged women with a virus-like particle vaccineRebecca T Emeny, Cosette M Wheeler, Kathrin U Jansen, et al.
Expert Review of Vaccines|September 24, 2013
Translational sciences approach to RSV vaccine developmentVanessa Kurzweil, Roderick Tang, Mark Galinski, et al.
Clinical & Translational Immunology|May 2, 2022
Validation and performance of a multiplex serology assay to quantify antibody responses following SARS-CoV-2 infection or vaccinationDeidre Wilkins, Anastasia A Aksyuk, Alexey Ruzin, et al.
Pageof 10

Showing results (21-30 of 99) with videos related to

Sort By:
Pageof 10
Human Vaccines|July 6, 2007
Antibodies from women immunized with Gardasil cross-neutralize HPV 45 pseudovirionsJudith F Smith, Michelle Brownlow, Martha Brown, et al.
Msphere|April 26, 2019
Development and Standardization of a High-Throughput Multiplex Immunoassay for the Simultaneous Quantification of Specific Antibodies to Five Respiratory Syncytial Virus ProteinsRutger M Schepp, Cornelis A M de Haan, Deidre Wilkins, et al.
Respiratory Research|April 2, 2020
Microbial burden and viral exacerbations in a longitudinal multicenter COPD cohortJerome Bouquet, David E Tabor, Jonathan S Silver, et al.
Vaccine|April 23, 2016
A phase 1a, first-in-human, randomized study of a respiratory syncytial virus F protein vaccine with and without a toll-like receptor-4 agonist and stable emulsion adjuvantJudith Falloon, Fei Ji, Craig Curtis, et al.
Influenza and Other Respiratory Viruses|March 4, 2020
Characterization of human respiratory syncytial virus (RSV) isolated from HIV-exposed-uninfected and HIV-unexposed infants in South Africa during 2015-2017Hui Liu, Bin Lu, David E Tabor, et al.
Antimicrobial Agents and Chemotherapy|November 1, 2016
Safety, Tolerability, and Pharmacokinetics of MEDI4893, an Investigational, Extended-Half-Life, Anti-Staphylococcus aureus Alpha-Toxin Human Monoclonal Antibody, in Healthy AdultsXiang-Qing Yu, Gabriel J Robbie, Yuling Wu, et al.
Infection and Immunity|December 22, 2017
Prevalence of IgG and Neutralizing Antibodies against Staphylococcus aureus Alpha-Toxin in Healthy Human Subjects and Diverse Patient PopulationsYuling Wu, Xu Liu, Ahmad Akhgar, et al.
Journal of Virology|July 5, 2002
Priming of human papillomavirus type 11-specific humoral and cellular immune responses in college-aged women with a virus-like particle vaccineRebecca T Emeny, Cosette M Wheeler, Kathrin U Jansen, et al.
Expert Review of Vaccines|September 24, 2013
Translational sciences approach to RSV vaccine developmentVanessa Kurzweil, Roderick Tang, Mark Galinski, et al.
Clinical & Translational Immunology|May 2, 2022
Validation and performance of a multiplex serology assay to quantify antibody responses following SARS-CoV-2 infection or vaccinationDeidre Wilkins, Anastasia A Aksyuk, Alexey Ruzin, et al.
Pageof 10